Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease
Abstract There is a paucity of studies investigating the impact of chronic corticosteroid use for coexisting conditions in patients with Coronavirus Disease 2019 (COVID-19). Additionally, the information regarding the impact of chronic liver disease (CLD) on COVID-19 outcomes is evolving. Our study...
Main Authors: | Hammad Liaquat, Brittney Shupp, Samantha Rollins, Yecheskel Schneider, Ayaz Matin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-98778-z |
Similar Items
-
Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients
by: Brittney Shupp, et al.
Published: (2022-05-01) -
Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
by: Hyeji Kim, et al.
Published: (2018-12-01) -
Corticosteroid therapy for liver abscesses in a neonate with Chronic granulomatous disease
by: Azadeh Darabi, et al.
Published: (2021-09-01) -
Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History
by: Andrea S. Melani, et al.
Published: (2024-02-01) -
Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease
by: Kyung-Sue Shin, et al.
Published: (2016-04-01)